DemurisTM is an antibiotic discovery company with unique and world leading expertise in key technologies of natural product sourcing and target-based screening.

Demuris has acquired a major collection of actinomycete bacteria, which are a huge and diverse group of microorganisms that produce many natural product molecules with therapeutic and industrial importance.

This collection is unprecedented in its rich diversity, having been collected over a 40 year period, involving several hundred people years of effort, by the world leading expert on the systematics of these organisms, Prof. Mike Goodfellow.

Demuris is using its world leading expertise in antibiotic screening technologies, developed over many years by Prof. Jeff Errington and colleagues, to search the collection for novel antibiotic leads.

The collection is also being made available to potential partners and collaborators as a valuable screening resource applicable to a wide range of therapeutic and industrial problems.